Board MeetingOutcome of Board Meeting
Divi's Labs approved robust Q4 and FY26 consolidated results: PAT hit ₹751 Cr for Q4 and ₹2568 Cr for the full year.
Divi's Laboratories LimitedDIVISLAB · Filed with the exchange
The Board also declared a ₹30/share dividend (1500%) for FY26, pending shareholder approval at the AGM on Aug 10.
No comments yet. Be the first.